How to evaluate healthcare AI app development companies in 2026 — what separates AI experiment shops from production healthcare AI engineering teams, with the four evaluation criteria that actually matter when you’re scoping a build.
Our experts are ready to understand your business goals.
Healthcare AI app development companies in 2026 fall into three tiers: AI experiment shops (no healthcare expertise, no BAA infrastructure, build prototypes that never ship to production), generalist app developers with AI features (broad capability, shallow healthcare depth, struggle with HIPAA and EHR integration), and healthcare AI engineering shops (deep EHR integration experience, signed BAAs with AI providers, FDA SaMD pathway awareness, production deployments in clinical settings). The evaluation criteria that separate these tiers are EHR integration depth, BAA paper trail with AI providers, FDA SaMD experience, and shipped clinical AI production examples. Engagement pricing for production healthcare AI development typically runs $45K–$450K depending on use case complexity.
Ask how many Epic, Cerner-Oracle, Athena, and Allscripts integrations they’ve shipped to production. The honest answer is a number, not a marketing phrase. Healthcare AI lives or dies on EHR integration — if the company can’t ship a FHIR R4 write-back or a SMART on FHIR launch, the AI never reaches clinicians.
Ask if they have signed BAAs with OpenAI, Anthropic, AWS Bedrock, and Google. Ask to see a redacted copy. Ask about their zero-data-retention configuration. AI features shipped to production without BAA coverage are a HIPAA exposure regardless of how clever the engineering is.
Most AI features in healthcare don’t need FDA clearance. But imaging AI, autonomous diagnosis, and clinical-decision-mandating AI usually do. Ask if the company has shipped FDA SaMD pathway engagements before. If not, you’ll discover the gap at the worst time.
Ask for verified case studies. Not pilots. Not demos. Production deployments with named hospital systems, documented outcomes, and a real implementation timeline. AI experiment shops have impressive demos; healthcare AI engineering shops have production deployments.
AI experiment shops charge time-and-materials and blow past budgets. Healthcare AI engineering shops productize their engagements — fixed price, fixed scope, fixed timeline. If the company can’t quote a fixed price for a Discovery Sprint, the engagement risk is on you.
Ask who’s on the engineering team. Ask how many years of healthcare-only experience they have. Ask if anyone on the team has shipped a FHIR integration. The team’s healthcare depth is the predictor of how much of the engagement is real work versus learning on your dollar.
Generalist AI consultancies that picked up healthcare as a vertical in 2023–2024. Strong on AI engineering, weak on healthcare-specific constraints. Common patterns: no BAA infrastructure, no EHR integration experience, no FDA SaMD awareness, prototypes that demo well but never reach clinical production.
When this tier fits: pre-MVP exploration where the goal is to test whether an AI feature is technically feasible. The Discovery Sprint they ship is real work; the production deployment is where the engagement falls apart.
Healthcare-focused app development shops that added AI as a service line in 2024–2025. Strong on HIPAA basics and FHIR integration, weaker on production AI engineering. Common patterns: BAA paperwork exists but is generic, AI features are wrapper-on-OpenAI rather than evaluated production systems, no fine-tuning or on-prem deployment capability.
When this tier fits: lower-risk AI features like patient engagement chatbots, AI scheduling, and plain-language explanations where the AI is augmenting an existing app rather than driving clinical workflow.
Healthcare-only engineering teams with 10+ years of EHR integration experience and modern AI engineering depth. Common patterns: signed BAAs with every major AI provider, shipped FDA SaMD engagements, productized fixed-price tiers, verified clinical production case studies, on-prem LLM and fine-tuning capability.
When this tier fits: clinical AI features where the deployment has to ship to production, integrate with the EHR, and survive a SOC 2 or HITRUST audit. Higher engagement cost, dramatically lower risk of stalling at pilot.
Building healthcare software since 2013. 785+ healthcare implementations shipped to production. The Taction Mirth Connect practice is older than the AI industry itself.
Epic, Cerner-Oracle, Athena, Allscripts, eClinicalWorks, NextGen, Meditech. FHIR R4, HL7 v2, CDA, SMART on FHIR. Both read and write-back patterns.
Across 785+ healthcare implementations. SOC 2 Type II and HITRUST audit-ready documentation patterns on every engagement.
Pre-signed BAA templates with OpenAI, Anthropic, AWS Bedrock, and Google. Zero-data-retention configuration verified in writing. Audit logging on every model output.
$60K FDA SaMD pathway assessment add-on. Imaging AI, autonomous diagnosis, and clinical-decision-mandating AI engagements include the SaMD pathway from day 1.
The Taction PROOF Framework — Prototype, Refine, Operate, Observe, Formalize. $45K Discovery Sprint, $95K Production-Ready Sprint, $145K Pilot-Ready Sprint. Production deployments $120K–$450K.
Ambient documentation, AI medical coding, predictive deterioration, AI prior authorization, AI scheduling, multilingual chat, AI symptom triage, AI imaging triage. Production deployments with documented outcome data.
Free 30-min architecture call. We’ll scope your use case, EHR integration path, and the right tier for your timeline.
Get my estimate
Six evaluation criteria: EHR integration depth (ask for the count of shipped Epic/Cerner/Athena/Allscripts integrations), BAA paper trail with AI providers, FDA SaMD experience, production case studies (not pilots, not demos), productized fixed-price tiers, and healthcare-specific engineering team. Generalist AI shops fail on most of these.
AI experiment shops build prototypes that demo well; healthcare AI engineering shops ship production deployments with EHR integration, BAA coverage, audit logging, and override-and-audit UX. The difference shows up at month 4 when the prototype has to become production.
Productized fixed-price tiers: $45K Discovery Sprint (4 weeks), $95K Production-Ready Sprint (8 weeks), $145K Pilot-Ready Sprint (12 weeks). Production deployments range $120K–$450K depending on use case, EHR integration scope, and FDA pathway. Multi-feature enterprise platforms run $250K–$500K.
How many Epic/Cerner/Athena/Allscripts integrations have you shipped to production? Do you have signed BAAs with OpenAI, Anthropic, AWS Bedrock, and Google? Can you show me a redacted BAA? Have you shipped an FDA SaMD pathway engagement? Can I see three verified production case studies with named clinical settings? What’s your fixed price for a Discovery Sprint?
Yes. Every Taction healthcare engagement is BAA-covered from day 1. We sign BAAs on the engineering services contract, and our deployments include pre-signed BAA templates between you and every AI provider in the inference path.
Ambient clinical documentation in a single department, deployed to one EHR via FHIR write-back. 8–12 weeks, $95K–$145K, clinically loved within weeks of pilot. The $45K Discovery Sprint is the de-risked entry point — 4 weeks to a working concept and a written go/no-go for production.
Your email address will not be published. Required fields are marked *
Our expert reaches out shortly after receiving your request and analyzing your requirements.
If needed, we sign an NDA to protect your privacy.
We request additional information to better understand and analyze your project.
We schedule a call to discuss your project, goals. and priorities, and provide preliminary feedback.
If you're satisfied, we finalize the agreement and start your project.